Updated 12:17 GMT, 21 Nov 2026 SPX 6,910.39 -3.70% NDX 25,028.98 -5.61% VIX 35.89 +26.20% GOLD 3,515.40 -4.62% CL 83.98 +0.93% BTC 58,232.43 -0.96%
NAS100 25,029 −5.61% S&P 6,910 −3.70% GOLD $3,515 −4.62% BTC $58,232 −0.96% VIX 35.89 +26.20% latest tape · as of 12:17 UTC
The Screen · Healthcare · Biotechnology

ORIC Pharmaceuticals, Inc.

ORIC · Nasdaq · USD · Market cap $928M · 104 employees

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States.

Not enough data to screen yet
7.36 USD

Price as of 20 Nov 2026Daily close, not a live quote

Screened 2026-11-20 · the tape above runs as of 12:17 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price7.36 USD at the 20 Nov 2026 close
  • Fair valueUnder review: our model's value is 2.94x the price, above our 2.00x limit.
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenNot yet scored
  • OptionsOpen interest leans to puts (put/call 34.60)
  • Last reviewed20 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-11-20).

Current read
Distribution ?
Screened · screened 2026-11-20
  • Trend Distribution
  • Insiders insiders sold, $86,524, latest filing 2026-10-01
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 34.60, read 2026-11-20
  • Ethical screen not yet scored
Price7.36 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-11-04Read Distribution9.59-23.3% to today ✓Accumulation gives way to Distribution after a 29% slide in 5 weeks
2026-10-02Read Accumulation13.50-45.5% to today Markdown gives way to Accumulation after a 63% rise in 3 weeks
2026-09-08Read Markdown8.27-11.0% to today ✓Markup gives way to Markdown first Markdown read since July
2026-08-07Read Markup8.27-11.0% to today Markdown gives way to Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

ORIC Pharmaceuticals, Inc. holds its Distribution at $7.36. The statistical read favours the buyers, held for 17 days.

As held on the ledger · 2026-11-20
PhaseDistribution · caution
Quantitative stateThe statistical read favours the buyers, held for 17 days
Price at the screen$7.36
ValuationN/A trailing · -5.31 forward price to earnings
Values screenNot scored · score 70.0
Beta0.98
The Workings

Five Screens: ORIC's Results

This security has not been fully scored against the values screen yet.

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 0.81% Below 33% Pass
Interest-bearing cash 27.09% Below 33% Pass
Receivables 11.17% Below 49% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

The Read, in Plain English

ORIC Pharmaceuticals, clears the business-activity screen and the figures we can measure look clean, but its income-purity figure is still pending, so the verdict is not final yet.

Read as at 20 Nov 2026. It updates when the underlying figures move, and past reads are kept below. How we screen.

What the Numbers Say It Is Worth

The Fair Value Range

Fair value under review. Our model's value is 2.94x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.

Method.

The Street's Range
15.00Street low 23.50Street average 27.00Street high 7.36Price

Street: 14 covering, consensus Strong Buy. Average target +219%.

Chart
The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E-5.3x
EPS, trailing-1.32
EPS, forward-1.69
Profit margin0.0%currently unprofitable
Return on equity-39.8%not currently earning a positive return on equity
FCF yield-7.42%
Debt to equity1.57a meaningful debt load worth watching
Current ratio13.19comfortably covers its short-term bills
Beta0.98steadier than the market
Short interest, float0.16%
52-week range7.23 - 14.68
Market cap$928M
Employees104

ORIC-specific watchpoints · The things to watch: it's a small-cap, so the share price can swing harder than the market; as a biotechnology name, trial and regulatory outcomes can move it sharply either way; it carries a real debt load, which raises the stakes if revenue slips.

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-20 Distribution $7.65 -2.7% Entry 21
2026-11-16 Distribution $7.86 +0.0% Entry 20
2026-11-15 Distribution $7.86 -12.7% Entry 19
2026-11-12 Distribution $9.00 +1.0% Entry 18
2026-11-11 Distribution $8.91 -3.5% Entry 17
2026-11-10 Distribution $9.23 +4.6% Entry 16
2026-11-09 Distribution $8.82 +0.0% Entry 15
2026-11-08 Distribution $8.82 +0.0% Entry 14
2026-11-07 Distribution $8.82 +3.9% Entry 13
2026-11-06 Distribution $8.49 -9.1% Entry 12

Earnings landed in this window. Ethical screening: not fully scored yet.

Written on its date, before the outcome; never pruned.

Latest News · What the Market Is Reading on ORIC

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in ORIC's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · ORIC
DateInsiderTitleTypeSharesValue
2026-10-01 Heyman Richard A. Dir S - Sale+OE 6,700 $86,524
2026-09-28 Piscitelli Dominic CFO S - Sale+OE 13,400 $181,258
2026-09-24 Piscitelli Dominic CFO S - Sale+OE 600 $8,103

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $8.99 -15.0% · $850 -15.0%
2 months $10.15 -24.7% · $753 -24.7%
3 months $11.76 -35.0% · $650 -35.0%
6 months $9.69 -21.1% · $789 -21.1%
1 year $9.75 -21.6% · $784 -21.6%
2 years $8.60 -11.1% · $889 -11.1%
3 years $5.15 +48.5% · $1,485 +48.5%
5 years $19.52 -60.8% · $392 -60.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever ORIC does next, these words stay.

ORIC Pharmaceuticals, Inc. · ORIC · Distribution · $7.36
Recorded 2026-11-20 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.